Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 7
2013 3
2014 1
2015 7
2017 2
2019 1
2020 2
2021 7
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Among authors: rojas rivera j. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
The authors reply.
Fernández-Juárez G, Rojas-Rivera J, Praga M. Fernández-Juárez G, et al. Among authors: rojas rivera j. Kidney Int. 2021 May;99(5):1243. doi: 10.1016/j.kint.2021.02.013. Kidney Int. 2021. PMID: 33892866 No abstract available.
The authors reply.
Fernández-Juárez G, Rojas-Rivera J, Praga M. Fernández-Juárez G, et al. Among authors: rojas rivera j. Kidney Int. 2021 Apr;99(4):1024-1025. doi: 10.1016/j.kint.2020.12.030. Kidney Int. 2021. PMID: 33745533 No abstract available.
Belimumab in Lupus Nephritis.
Rojas-Rivera J, Ortiz A, Carriazo S. Rojas-Rivera J, et al. N Engl J Med. 2021 Jan 14;384(2):187. doi: 10.1056/NEJMc2032520. N Engl J Med. 2021. PMID: 33497557 No abstract available.
Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis.
Avello A, Fernandez-Prado R, Santos-Sanchez-Rey B, Rojas-Rivera J, Ortiz A. Avello A, et al. Among authors: rojas rivera j. Clin Kidney J. 2020 Nov 9;14(1):18-22. doi: 10.1093/ckj/sfaa181. eCollection 2021 Jan. Clin Kidney J. 2020. PMID: 33564403 Free PMC article.
Atrasentan for the treatment of diabetic nephropathy.
Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C. Egido J, et al. Among authors: rojas rivera j. Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Expert Opin Investig Drugs. 2017. PMID: 28468519 Review.
Vitamin D receptor activation and cardiovascular disease.
Gonzalez-Parra E, Rojas-Rivera J, Tuñón J, Praga M, Ortiz A, Egido J. Gonzalez-Parra E, et al. Among authors: rojas rivera j. Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv17-21. doi: 10.1093/ndt/gfs534. Nephrol Dial Transplant. 2012. PMID: 23258805 Review.
Use of sevelamer in chronic kidney disease: beyond phosphorus control.
Rodríguez-Osorio L, Zambrano DP, Gracia-Iguacel C, Rojas-Rivera J, Ortiz A, Egido J, González Parra E. Rodríguez-Osorio L, et al. Among authors: rojas rivera j. Nefrologia. 2015;35(2):207-17. doi: 10.1016/j.nefro.2015.05.022. Epub 2015 Jun 23. Nefrologia. 2015. PMID: 26300515 Free article. Review. English, Spanish.
27 results